Araştırma Makalesi

The Relationship of Hematological Parameters with Metabolic Syndrome in Type 1 and Type 2 Psoriasis

Cilt: 32 Sayı: 2 29 Nisan 2022
PDF İndir
EN TR

The Relationship of Hematological Parameters with Metabolic Syndrome in Type 1 and Type 2 Psoriasis

Öz

Objective: Psoriasis is a chronic, inflammatory disease with a rate of 2% in the population, with periods of remission and exacerbation. Psoriasis has been accepted as an independent risk factor for cardiovascular diseases and is known to be closely related to metabolic syndrome. It is known that the mean platelet volume (MPV), the platelet distribution width (PDW), the red blood cell distribution width (RDW) levels are parameters predicting systemic inflammation. Studies have found that some of these parameters can be used to predict metabolic syndrome in patients with psoriasis. In the literature, there is no study showing the relationship between the frequency of metabolic syndrome (MS) and hematological parameters by evaluating type 1 and type 2 psoriasis separately. Materials and Methods: A total of 186 participants were included in the study, 93 patients over 18 years of age with psoriasis diagnosed and 93 age and gender equivalent control groups, who applied to the dermatology clinic. Results: While PDW was significantly different between psoriasis and control group, RDW was significantly different in the type 2 psoriasis group compared to the type 1 psoriasis group. Although MPV, RDW, and PDW were higher in the MS groups for both type 1 and type 2 psoriasis groups, and they did not create a statistically significant difference in any of them. Conclusions: This study showed that the frequency of MS and related parameters were different between patients with type 1 and type 2 psoriasis, and we found that type 2 psoriasis was more associated with MS. In addition, we think that among the inflammatory parameters, especially RDW, may be an important marker for type 2 and type 1 psoriasis and comorbidities.

Anahtar Kelimeler

Psoriasis, metabolic syndrome, hematological parameters

Kaynakça

  1. Referans1. Temiz SA, Özer İ, Ataseven A, Dursun R, Uyar M. The effect of smoking on the psoriasis: Is it related to nail involvement?. Dermatologic Therapy. 2020;33(6):e13960.
  2. Referans2. Delaporte E. Immune-mediated inflammatory diseases and psoriasis. Ann Dermatol Venereol 2008;135:269-74.
  3. Referans3. Daye M, Temiz SA, Isık B. The relationship between lichen planus and metabolic syndrome. J Cosmet Dermatol. 2020;00:1–5. https://doi.org/10.1111/ jocd.13905
  4. Referans4. Günaydin A, Aytimur D, Özdemir, F. Psoriasis ve metabolik sendrom/Psoriasis and metabolic syndrome. Turkderm 2014;48(2),95.
  5. Referans5. Dogan S, Atakan N. Red blood cell distribution width is a reliable marker of inflammation in plaque psoriasis. Acta dermatovenerologica Croatica, 2017;25(1),26-26.
  6. Referans6. Korkmaz S. Mean platelet volume and platelet distribution width levels in patients with mild psoriasis vulgaris with metabolic syndrome. Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii, 2018;35(4),367.
  7. Referans7. Gürer MA, Adışen E. Psoriasis, Genel Bilgiler, Epidemiyoloji. Archives of the Turkish Dermatology & Venerology/Turkderm, 2008;42.
  8. Referans8. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Archives of dermatological research 2007;298(7):321.
  9. Referans9. Cohen AD, Sherf M, Vidavsky L, Vardy DA, Shapiro J, Meyerovitch J. Association between psoriasis and the metabolic syndrome. Dermatology 2008;216(2):152-155.
  10. Referans10. Langan SM, Seminara NM, Shin DB, Troxel AB, Kimmel SE, Mehta NN, et al. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. Journal of Investigative Dermatology 2012;132(3):556-562,

Kaynak Göster

APA
Daye, M., & Temiz, S. A. (2022). The Relationship of Hematological Parameters with Metabolic Syndrome in Type 1 and Type 2 Psoriasis. Genel Tıp Dergisi, 32(2), 150-153. https://doi.org/10.54005/geneltip.1029729
AMA
1.Daye M, Temiz SA. The Relationship of Hematological Parameters with Metabolic Syndrome in Type 1 and Type 2 Psoriasis. Genel Tıp Derg. 2022;32(2):150-153. doi:10.54005/geneltip.1029729
Chicago
Daye, Munise, ve Selami Aykut Temiz. 2022. “The Relationship of Hematological Parameters with Metabolic Syndrome in Type 1 and Type 2 Psoriasis”. Genel Tıp Dergisi 32 (2): 150-53. https://doi.org/10.54005/geneltip.1029729.
EndNote
Daye M, Temiz SA (01 Nisan 2022) The Relationship of Hematological Parameters with Metabolic Syndrome in Type 1 and Type 2 Psoriasis. Genel Tıp Dergisi 32 2 150–153.
IEEE
[1]M. Daye ve S. A. Temiz, “The Relationship of Hematological Parameters with Metabolic Syndrome in Type 1 and Type 2 Psoriasis”, Genel Tıp Derg, c. 32, sy 2, ss. 150–153, Nis. 2022, doi: 10.54005/geneltip.1029729.
ISNAD
Daye, Munise - Temiz, Selami Aykut. “The Relationship of Hematological Parameters with Metabolic Syndrome in Type 1 and Type 2 Psoriasis”. Genel Tıp Dergisi 32/2 (01 Nisan 2022): 150-153. https://doi.org/10.54005/geneltip.1029729.
JAMA
1.Daye M, Temiz SA. The Relationship of Hematological Parameters with Metabolic Syndrome in Type 1 and Type 2 Psoriasis. Genel Tıp Derg. 2022;32:150–153.
MLA
Daye, Munise, ve Selami Aykut Temiz. “The Relationship of Hematological Parameters with Metabolic Syndrome in Type 1 and Type 2 Psoriasis”. Genel Tıp Dergisi, c. 32, sy 2, Nisan 2022, ss. 150-3, doi:10.54005/geneltip.1029729.
Vancouver
1.Munise Daye, Selami Aykut Temiz. The Relationship of Hematological Parameters with Metabolic Syndrome in Type 1 and Type 2 Psoriasis. Genel Tıp Derg. 01 Nisan 2022;32(2):150-3. doi:10.54005/geneltip.1029729